RxDoctor Payments Data

Tariq Salam, MD

Clinical Cardiac Electrophysiology · Tacoma, WANPI 1043294291

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Biosense Webster, Inc. accounts for 70.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $31,449 and has fallen 86.8% since, to $4,148 in 2025.

$56,219in general payments, 2019–2025

Across 170 payments — averaging $330.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$40K
  • Medical Device Business Services, Inc.$5K
  • Abbott$3K
  • Medtronic$3K
  • Baylis Medical Company Inc$2K
  • Bayer$1K
  • plus $1K from 4 others
$65,751in research payments, 2019–2025

Across 22 payments — averaging $2988.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$43K
  • Medtronic$23K

What the payments were for

  • Consulting fees$20,65037%
  • Speaking & faculty fees$1,9503%
  • Travel & lodging$26,33347%
  • Food & beverage$7,28613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,219 in reported general payments places this provider in the 85th percentile of 68 clinical cardiac electrophysiology providers in Washington.

See all clinical cardiac electrophysiology providers in Washington

Medicare billing

Part B allowed, 2024
$354,563
Medicare patients
898
Services billed
5,045

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban285$284,910
XareltoRivaroxaban104$132,931
Dabigatran EtexilateDabigatran Etexilate Mesylate22$4,472
Flecainide Acetate92$2,484
Propafenone Hcl ErPropafenone Hcl13$2,355
Metoprolol Succinate217$2,260
Dofetilide12$1,723
Colchicine51$1,389
Amiodarone Hcl56$902
Dilt-XrDiltiazem Hcl23$765
SotalolSotalol Hcl28$546
Diltiazem 24hr Er (Xr)Diltiazem Hcl28$529
Diltiazem 24hr Er (Cd)Diltiazem Hcl19$398
Cartia XtDiltiazem Hcl15$372
ClopidogrelClopidogrel Bisulfate45$280

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →